Review and recommendations on deformable image registration uncertainties for radiotherapy applications
Deformable image registration (DIR) is a versatile tool used in many applications in
radiotherapy (RT). DIR algorithms have been implemented in many commercial treatment …
radiotherapy (RT). DIR algorithms have been implemented in many commercial treatment …
Radiotherapy for Advanced Esophageal Cancer: From Palliation to Curation
Z Xin, Q Liu, D Ai, K Chen, E Mariamidze… - … Treatment Options in …, 2023 - Springer
Opinion statement Esophageal cancer is a global health problem, which is 7th most
common and 6th most deadly cancer. It has been the era of immuno-oncology for …
common and 6th most deadly cancer. It has been the era of immuno-oncology for …
Treatment plan optimisation for reirradiation
L Murray, C Thompson, C Pagett, J Lilley… - Radiotherapy and …, 2023 - Elsevier
Abstract Background The STRIDeR (Support Tool for Re-Irradiation Decisions guided by
Radiobiology) project aims to create a clinically viable re-irradiation planning pathway within …
Radiobiology) project aims to create a clinically viable re-irradiation planning pathway within …
[HTML][HTML] Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
J Willmann, AL Appelt, P Balermpas… - Radiotherapy and …, 2023 - Elsevier
Background Re-irradiation is an increasingly utilized treatment for recurrent, metastatic or
new malignancies after previous radiotherapy. It is unclear how re-irradiation is applied in …
new malignancies after previous radiotherapy. It is unclear how re-irradiation is applied in …
Brain re-irradiation robustly accounting for previously delivered dose
C Thompson, C Pagett, J Lilley, S Svensson… - Cancers, 2023 - mdpi.com
Simple Summary Repeat radiotherapy to a part of the body that has previously been treated
with radiotherapy is challenging. It is difficult to determine where the dose previously went …
with radiotherapy is challenging. It is difficult to determine where the dose previously went …
Proton beam therapy in the reirradiation setting of brain and base of skull tumour recurrences
The therapeutic management of local tumour recurrence after a first course of radical
radiotherapy is always complex. Surgery and reirradiation carry increased morbidity due to …
radiotherapy is always complex. Surgery and reirradiation carry increased morbidity due to …
Re-irradiation by stereotactic radiotherapy of brain metastases in the case of local recurrence
R Touati, V Bourbonne, G Dissaux, G Goasduff… - Cancers, 2023 - mdpi.com
Simple Summary This is the first study to evaluate the outcomes of repeated salvage
stereotactic radiotherapy (SRT) for the local recurrence of brain metastases after initial …
stereotactic radiotherapy (SRT) for the local recurrence of brain metastases after initial …
Phase 2 trial of consolidation pembrolizumab after proton reirradiation for thoracic recurrences of non-small cell lung cancer
N Yegya-Raman, AT Berman, CA Ciunci… - International Journal of …, 2024 - Elsevier
Purpose Reirradiation (reRT) with proton beam therapy (PBT) may offer a chance of cure
while minimizing toxicity for patients with isolated intrathoracic recurrences of non-small cell …
while minimizing toxicity for patients with isolated intrathoracic recurrences of non-small cell …
Prospective randomized clinical studies involving reirradiation: update of a systematic review
C Nieder, J Willmann, NH Andratschke - Strahlentherapie und Onkologie, 2023 - Springer
Background Reirradiation is a potentially useful option for many patients with recurrent
cancer, aiming at cure or symptom palliation, depending on disease/recurrence type and …
cancer, aiming at cure or symptom palliation, depending on disease/recurrence type and …
Dose-accumulation analysis of target and organs at risk with clinical outcome after re-irradiation of diffuse midline glioma
DE Østergaard, I Wahlstedt, M Jørgensen… - Acta …, 2023 - Taylor & Francis
Diffuse midline glioma (DMG) is the most common brainstem cancer among children [1]. It is
a fatal disease with less than 5% of patients alive 2years from diagnosis [2]. Despite …
a fatal disease with less than 5% of patients alive 2years from diagnosis [2]. Despite …